THÉRAPIE CELLULAIRE ADOPTIVE UTILISANT UN AGONISTE DU RÉCEPTEUR GAMMA ORPHELIN ASSOCIÉ AU RÉCEPTEUR DE L'ACIDE RÉTINOÏQUE ET MÉTHODES THÉRAPEUTIQUES ASSOCIÉES

• 收藏
• 分享

专利权人:

Lycera Corporation

发明人:

申请号：

EP15755439.5

公开号：

EP3110429A4

申请日:

2015.02.27

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The invention relates to medical therapy using an agonist of the retinoic acid receptor-related orphan receptor gamma (RORγ) and provides adoptive cellular therapies using an agonist of RORγ, populations of lymphocyte cells that have been exposed to an agonist of RORγ, populations of dendritic cells that have been exposed to an agonist of RORγ, pharmaceutical compositions, and methods for enhancing therapeutic effects of lymphocyte cells and/or dendritic cells in a patient by administering an agonist of RORγ to a patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/